Get started
CONMED CorporationCONMED CorporationCONMED Corporation

CONMED Corporation

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Forecast Seasonals Bonds

CNMD chart


Full chart

CNMD upcoming earnings

Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪2.12 B‬ USD
Dividend yield (indicated)
1.17%
Price to earnings Ratio (TTM)
16.59
Basic EPS (TTM)
4.28 USD
Net income (FY)
‪64.46 M‬ USD
Revenue (FY)
‪1.24 B‬ USD
Shares float
‪30.03 M‬
Beta (1Y)
0.12

Employees


Employees (FY)
‪4 K‬
Change (1Y)
−100 −2.44%
Revenue / Employee (1Y)
‪310.24 K‬ USD
Net income / Employee (1Y)
‪16.11 K‬ USD

About CONMED Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Curt R. Hartman
Website
conmed.com
Headquarters
Largo
Founded
1970
FIGI
BBG000BFZVH8
CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. Its products include AirSeal and insufflation, allograft cartilage and tissue, arthroplasty, biliary and endoscopic ultrasound, biomedical sensors and electrodes, biopsy and polypectomy, dilators and accessories, electrosurgical units, fixation devices, hemostasis, implants and suture anchors, infection prevention, patient positioning, and related products. The company was founded by Eugene R. Corasanti in 1970 and is headquartered in Largo, FL.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

CNMD news



Technicals

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

CNMD highest yielding bonds


CNMD5600366
CONMED Corporation 2.25% 15-JUN-2027
Yield to maturity
6.20%
Maturity date
Jun 15, 2027

Explore more bonds 

Frequently Asked Questions


The current price of CNMD is 68.63 USD — it has decreased by −1.96% in the past 24 hours. Watch CONMED Corporation stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NYSE exchange CONMED Corporation stocks are traded under the ticker CNMD.
CNMD stock has fallen by −6.38% compared to the previous week, the month change is a −4.35% fall, over the last year CONMED Corporation has showed a −37.35% decrease.
We've gathered analysts' opinions on CONMED Corporation future price: according to them, CNMD price has a max estimate of 97.00 USD and a min estimate of 72.00 USD. Watch CNMD chart and read a more detailed CONMED Corporation stock forecast: see what analysts think of CONMED Corporation and suggest that you do with its stocks.
CNMD reached its all-time high on Nov 5, 2021 with the price of 159.11 USD, and its all-time low was 0.12 USD and was reached on Oct 20, 1987. View more price dynamics on CNMD chart.
See other stocks reaching their highest and lowest prices.
CNMD stock is 4.90% volatile and has beta coefficient of 0.12. Track CONMED Corporation stock price on the chart and check out the list of the most volatile stocks — is CONMED Corporation there?
Today CONMED Corporation has the market capitalization of ‪2.12 B‬, it has decreased by −2.85% over the last week.
Yes, you can track CONMED Corporation financials in yearly and quarterly reports right on TradingView.
CONMED Corporation is going to release the next earnings report on Jan 30, 2025. Keep track of upcoming events with our Earnings Calendar.
CNMD earnings for the last quarter are 1.05 USD per share, whereas the estimation was 1.02 USD resulting in a 2.63% surprise. The estimated earnings for the next quarter are 1.21 USD per share. See more details about CONMED Corporation earnings.
CONMED Corporation revenue for the last quarter amounts to ‪316.70 M‬ USD, despite the estimated figure of ‪317.78 M‬ USD. In the next quarter, revenue is expected to reach ‪340.96 M‬ USD.
CNMD net income for the last quarter is ‪48.98 M‬ USD, while the quarter before that showed ‪29.98 M‬ USD of net income which accounts for 63.41% change. Track more CONMED Corporation financial stats to get the full picture.
Yes, CNMD dividends are paid quarterly. The last dividend per share was 0.20 USD. As of today, Dividend Yield (TTM)% is 1.17%. Tracking CONMED Corporation dividends might help you take more informed decisions.
As of Dec 22, 2024, the company has ‪4.00 K‬ employees. See our rating of the largest employees — is CONMED Corporation on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. CONMED Corporation EBITDA is ‪216.09 M‬ USD, and current EBITDA margin is 14.68%. See more stats in CONMED Corporation financial statements.
Like other stocks, CNMD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CONMED Corporation stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So CONMED Corporation technincal analysis shows the strong sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating CONMED Corporation stock shows the sell signal. See more of CONMED Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.